LATE-BREAKING ABSTRACT: IL-5 and IL-13 are predictors of asthma remission; results from a birth cohort

D. Neville, V. Patil, L. Lau, R. Kurukulaaratchy, H. Arshad (Southampton, United Kingdom)

Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Session: Monitoring asthma: genes, cells and molecules
Session type: Thematic Poster Session
Number: 1106
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Neville, V. Patil, L. Lau, R. Kurukulaaratchy, H. Arshad (Southampton, United Kingdom). LATE-BREAKING ABSTRACT: IL-5 and IL-13 are predictors of asthma remission; results from a birth cohort. Eur Respir J 2013; 42: Suppl. 57, 1106

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


TSLP as biomarker in asthma patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015


LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014


LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013

Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014

LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014

The prognostic value of IFN-gamma and IL-4 cytokines ratio and CD25+ lymphocytes blood content for asthma exacerbation
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015


LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


LATE-BREAKING ABSTRACT: Mode of delivery and asthma at school age in nine European birth cohorts
Source: International Congress 2016 – Early determinants of childhood asthma and allergy
Year: 2016

Serum levels of IL-10, IL-17F, and IL-33 in asthmatic patients of south India
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Serum Th2 cytokine profiles in mould sensitised adults from a large population-based cohort
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014